Substrate Induction of Osteogenesis from Marrow-Derived Mesenchymal Precursors
- 1 December 2005
- journal article
- Published by Mary Ann Liebert Inc in Stem Cells and Development
- Vol. 14 (6), 632-642
- https://doi.org/10.1089/scd.2005.14.632
Abstract
Therapeutic modalities aimed at bone regeneration are increasingly employing extracellular matrix (ECM) constituents to control bone marrow progenitor cell (BMPC) commitment, growth, and differentiation. However, the precise role these ECM elements play during stem cell differentiation remains unclear. (See also Salaszynk et al., Stem Cells Dev 14(6):608-620, 2005; and Schwartz et al., Stem Cells Dev. 14(6), 643-655, 2005, both in this issue.) Because bone formation ultimately begins with the recruitment and commitment of BMPCs into the osteogenic lineage, factors that enhance this process are clearly therapeutic targets. We hypothesized that BMPC attachment, proliferation, and osteogenic differentiation would be potentiated when cultured on ECM proteins normally found in the bone niche. To examine this, we cultured murine BMPCs on laminin-1, fibronectin, and collagen type-1 substrates for up to 14 days and assessed their homogeneity, attachment, proliferation, and expression of the specific bone lineage markers RUNX2, collagen-1, alkaline phosphatase, and osteocalcin. We found that freshly harvested mBMPCs contain a mixed population of progenitor cells and that the mesenchymal pool can be enriched by adherent culture in the presence of leucine methyl ester. Furthermore, mBMPCs attached to laminin, fibronectin, and collagen-1 with varying affinity up to 3 h (fibronectin>or=collagen>laminin), after which time no difference could be detected. Despite this, growth was unaffected; cells thereafter proliferated equally well on all substrates up to confluence (7 days). Notably, commitment to the osteoblast lineage (RUNX2) increased up to 14 days for cells cultured on the various substrates, yet no difference was observed at day 14 in the expression of collagen-1, alkaline phosphatase, or osteocalcin. We conclude that mBMPC differentiation down the osteoblastic lineage is time-dependent in osteogenic culture and that attachment to ECM matrices potentiates lineage commitment rather than growth.Keywords
This publication has 40 references indexed in Scilit:
- Core-binding factor α1 (Cbfa1) induces osteoblastic differentiation of C2C12 cells without interactions with Smad1 and Smad5Bone, 2002
- Isoform-Specific Attachment of Osteoprogenitors to Laminins: Mapping to the Short Arms of Laminin-1Experimental Cell Research, 1999
- Selective attachment of osteoprogenitors to lamininBone, 1999
- Integrin Expression and Function on Human Osteoblast-like CellsJournal of Bone and Mineral Research, 1997
- Regulation of human osteoblast integrin expression by orthopedic implant materialsBone, 1996
- Identification of integrin receptors on cultured human bone cellsJournal of Orthopaedic Research, 1994
- Pattern of gene expression following rat tibial marrow ablationJournal of Bone and Mineral Research, 1993
- Bone matrix mRNA expression in differentiating fetal bovine osteoblastsJournal of Bone and Mineral Research, 1992
- Integrins: Versatility, modulation, and signaling in cell adhesionCell, 1992
- Mesenchymal stem cellsJournal of Orthopaedic Research, 1991